The potential of three-dimensional printed stents in post-operative treatment of breast cancer  

作　　者：Junjuan Fan Min Wang Xianwen Wang 

机构地区：[1]Department of Pharmacy,The Fourth Affiliated Hospital of Soochow University,Suzhou,Jiangsu Province,China [2]School of Biomedical Engineering,Anhui Medical University,Hefei,Anhui Province,China

出　　处：《Biomaterials Translational》2024年第3期331-333,共3页生物材料转化电子杂志（英文）

基　　金：supported by the Basic and Clinical Cooperative Research and Promotion Program of Anhui Medical University(No.2021xkjT028);the Anhui Medical University Research Fund Youth Project(No.2023xkj018).

摘　　要：Breast cancer is among the most frequent cancers;it mostly strikes women and ranks second in female cancer fatality rates,behind only lung cancer.1 There is a need to create efficient treatments to eradicate leftover tumor cells because,although surgery has been the predominant clinical treatment technique for cancer,local tumor recurrence and metastasis may still occur following surgery.2 Typically prescribed as a neoadjuvant or auxiliary treatment to surgery,chemotherapy is a frequent and successful method of treating many cancer types.3 Systemic chemotherapy for breast cancer typically involves high dosages,which is associated with unpleasant side effects that are particularly noticeable,and chemotherapy treatment efficacy is poor.Chemotherapy resistance is easy to relapse.4 Based on patient requirements,local chemotherapy can help reconstruct after breast cancer surgery,which is one area where systemic chemotherapy falls short.The biomedical area,particularly medication distribution,has benefited greatly from the advancements made possible by three-dimensional(3D)printing technology,a relatively new manufacturing technique.

关 键 词：DOSAGE TREATMENT PRESCRIBED 

分 类 号：R730.5[医药卫生—肿瘤]